PATENT CLAIM ANALYSIS

Application Number: 16181098
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "130100"]

Abstract:
The present invention related to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. Specifically, the invention provides a method of identifying tumor specific neoantigens that alone or in combination with other tumor-associated peptides serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor responses.

Claim (Index 18):
The method of  claim 1 , wherein the cancer cells of the subject are cancer cells of a solid cancer, a leukemia or a lymphoma.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 98.0
- Lexical Diversity: 1.22727
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13108610', '15154543', '15466729', '14850864', '11942607']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7468988116110336
- 35 USC 102 Novelty (BERT): 0.6115266205817372
- Combined Prediction Score: 0.733361592508104
- Mean Citation Score: 379.90037
- Max Citation Score: 598.5436
- Similarity Product: 485.1610586992264

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test